Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
27.11.25
/
50%
€93.00
Target price
27.11.26
€117.12
Performance (%)
-15.59%
Price
27.02.26
€81.50
Summary
This prediction is currently active. The prediction for Rhythm Pharmaceuticals disappoints with a performance of -15.59%. This prediction currently runs until 27.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -4.118% | -4.118% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
-1.81%
27.02.26
27.02.26
